BridgeBio Oncology Therapeutics, Inc. GAAP EPS of -$0.49
Source: SeekingAlpha
2026-03-05 17:59:09 ET
More on BridgeBio Oncology Therapeutics, Inc.
- BridgeBio Oncology Therapeutics, Inc. (BBOT) Discusses Clinical Data Updates for BBO-8520, BBO-11818, and BBO-10203 Transcript
- BridgeBio Oncology Therapeutics: Promising KRAS Drug Developer - In My View, At Least
- BridgeBio Oncology gains outperform rating from Raymond James
- Seeking Alpha’s Quant Rating on BridgeBio Oncology Therapeutics, Inc.
- Historical earnings data for BridgeBio Oncology Therapeutics, Inc.
Read the full article on Seeking Alpha
For further details see:
BridgeBio Oncology Therapeutics, Inc. GAAP EPS of -$0.49
BridgeBio Oncology Therapeutics Inc Com
NASDAQ: BBOT
BBOT Trading
-0.25% G/L:
$10.095 Last:
180,114 Volume:
$10.45 Open:
